BE771330A - - Google Patents
Info
- Publication number
- BE771330A BE771330A BE771330A BE771330A BE771330A BE 771330 A BE771330 A BE 771330A BE 771330 A BE771330 A BE 771330A BE 771330 A BE771330 A BE 771330A BE 771330 A BE771330 A BE 771330A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2040510A DE2040510C3 (de) | 1970-08-14 | 1970-08-14 | Oxazole- und Thiazole eckige Klammer auf 5,4-d] azepin- Derivate |
| DE19712127267 DE2127267A1 (en) | 1971-06-02 | 1971-06-02 | 2-amino-4,5,7,8-tetrahydro-6h-thiazolo-or oxazolo(5,4-d) - azepines - as hypotensive, antiphlogistic, sedative and bechic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE771330A true BE771330A (en:Method) | 1972-02-14 |
Family
ID=25759588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE771330A BE771330A (en:Method) | 1970-08-14 | 1971-08-13 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US3804849A (en:Method) |
| JP (1) | JPS5246236B1 (en:Method) |
| AT (1) | AT310174B (en:Method) |
| AU (1) | AU462319B2 (en:Method) |
| BE (1) | BE771330A (en:Method) |
| BG (3) | BG17786A3 (en:Method) |
| CA (1) | CA965423A (en:Method) |
| CH (1) | CH571003A5 (en:Method) |
| CS (1) | CS178084B2 (en:Method) |
| DK (1) | DK136654C (en:Method) |
| ES (3) | ES393881A1 (en:Method) |
| FI (1) | FI54925C (en:Method) |
| FR (1) | FR2102192B1 (en:Method) |
| GB (1) | GB1321509A (en:Method) |
| HU (1) | HU162343B (en:Method) |
| IE (1) | IE35517B1 (en:Method) |
| IL (1) | IL37492A (en:Method) |
| NL (1) | NL168516C (en:Method) |
| NO (1) | NO131887C (en:Method) |
| PL (1) | PL85080B1 (en:Method) |
| RO (4) | RO60635A (en:Method) |
| SE (1) | SE380529B (en:Method) |
| YU (5) | YU35027B (en:Method) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2820808A1 (de) * | 1978-05-12 | 1979-11-22 | Thomae Gmbh Dr K | Arzneimittel mit einer antanginoesen wirksamkeit |
| EP0192098A2 (de) | 1985-02-06 | 1986-08-27 | Boehringer Ingelheim Kg | Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3907996A (en) * | 1970-08-14 | 1975-09-23 | Boehringer Sohn Ingelheim | Pharmaceutical composition containing a 2-amino-4,5,7,8-tetrahydro-6H-thiazolo or -oxazolo 5,4-D azepine and method of use |
| BE795257A (fr) * | 1972-02-10 | 1973-08-09 | Thomae Gmbh Dr K | Nouveaux oxazols |
| US4400378A (en) * | 1981-11-02 | 1983-08-23 | Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pharmaceutical composition for the treatment of glaucoma |
| US4826686A (en) * | 1985-12-14 | 1989-05-02 | Boehringer Ingelheim Kg | Therapeutic system |
| DE3820775A1 (de) * | 1988-06-20 | 1989-12-21 | Thomae Gmbh Dr K | Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel |
| JP3054738B2 (ja) * | 1988-07-22 | 2000-06-19 | 武田薬品工業株式会社 | チアゾロ［５，４―ｂ］アゼピン誘導体 |
| US5424431A (en) * | 1990-10-24 | 1995-06-13 | Yamanouchi Pharmaceutical Co., Ltd. | Thiazole derivatives |
| US6369222B1 (en) * | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
| ES2364081T5 (es) * | 2005-12-08 | 2019-08-20 | Huntsman Int Llc | Procedimiento para preparar diaminodifenilmetanos |
| WO2009082268A2 (ru) | 2007-12-21 | 2009-07-02 | Alla Chem, Llc | ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ |
| RU2374245C1 (ru) | 2008-08-22 | 2009-11-27 | Андрей Александрович Иващенко | Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство |
| EP2327704A4 (en) * | 2008-08-29 | 2012-05-09 | Shionogi & Co | RING-CONDENSED AZOL DERIVATIVE WITH PI3K-INHIBITING EFFECT |
| TWI537274B (zh) | 2011-03-14 | 2016-06-11 | 橘生藥品工業股份有限公司 | 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途 |
| EP2930175A4 (en) | 2012-12-10 | 2016-12-21 | Kissei Pharmaceutical | NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF |
| CN104031072A (zh) * | 2014-06-24 | 2014-09-10 | 重庆植恩药业有限公司 | 一种盐酸他利克索的制备方法 |
-
1971
- 1971-07-30 BG BG019142A patent/BG17786A3/xx unknown
- 1971-07-30 BG BG018197A patent/BG17968A3/xx unknown
- 1971-07-30 BG BG019141A patent/BG17785A3/xx unknown
- 1971-08-04 RO RO67900A patent/RO60635A/ro unknown
- 1971-08-04 RO RO70468A patent/RO59129A/ro unknown
- 1971-08-04 RO RO70469A patent/RO59925A/ro unknown
- 1971-08-04 ES ES393881A patent/ES393881A1/es not_active Expired
- 1971-08-04 RO RO70457A patent/RO59127A/ro unknown
- 1971-08-04 US US00169065A patent/US3804849A/en not_active Expired - Lifetime
- 1971-08-11 CH CH1180571A patent/CH571003A5/xx not_active IP Right Cessation
- 1971-08-12 DK DK394071A patent/DK136654C/da not_active IP Right Cessation
- 1971-08-12 HU HUTO858A patent/HU162343B/hu unknown
- 1971-08-12 IL IL37492A patent/IL37492A/xx unknown
- 1971-08-12 CS CS5856A patent/CS178084B2/cs unknown
- 1971-08-13 PL PL1971150004D patent/PL85080B1/pl unknown
- 1971-08-13 NL NLAANVRAGE7111176,A patent/NL168516C/xx not_active IP Right Cessation
- 1971-08-13 AT AT711071A patent/AT310174B/de active
- 1971-08-13 YU YU2084/71A patent/YU35027B/xx unknown
- 1971-08-13 FI FI2265/71A patent/FI54925C/fi active
- 1971-08-13 NO NO3034/71A patent/NO131887C/no unknown
- 1971-08-13 IE IE1027/71A patent/IE35517B1/xx unknown
- 1971-08-13 FR FR7129692A patent/FR2102192B1/fr not_active Expired
- 1971-08-13 BE BE771330A patent/BE771330A/xx unknown
- 1971-08-13 GB GB3816071A patent/GB1321509A/en not_active Expired
- 1971-08-13 CA CA120,522A patent/CA965423A/en not_active Expired
- 1971-08-13 SE SE7110347A patent/SE380529B/xx unknown
- 1971-08-13 JP JP46061588A patent/JPS5246236B1/ja active Pending
- 1971-08-16 AU AU32411/71A patent/AU462319B2/en not_active Expired
- 1971-10-28 ES ES396454A patent/ES396454A1/es not_active Expired
- 1971-10-28 ES ES396453A patent/ES396453A1/es not_active Expired
-
1978
- 1978-12-06 YU YU2884/78A patent/YU42168B/xx unknown
- 1978-12-08 YU YU2881/78A patent/YU35028B/xx unknown
- 1978-12-08 YU YU2882/78A patent/YU40542B/xx unknown
- 1978-12-08 YU YU2883/78A patent/YU35029B/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2820808A1 (de) * | 1978-05-12 | 1979-11-22 | Thomae Gmbh Dr K | Arzneimittel mit einer antanginoesen wirksamkeit |
| EP0005732A1 (de) * | 1978-05-12 | 1979-12-12 | Dr. Karl Thomae GmbH | Verwendung von 2-Amino-oxazolo- oder 2-Amino-thiazolo-[5,4-d]azepinen sowie deren Säureadditionssalzen zur Herstellung eines Arzneimittels für die Verwendung bei der Bekämpfung von Angina Pectoris |
| EP0192098A2 (de) | 1985-02-06 | 1986-08-27 | Boehringer Ingelheim Kg | Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels |